-
1
-
-
0026066944
-
Lifetime use of nursing home care
-
Kemper P, Murtaugh CM. Lifetime use of nursing home care. N Engl J Med 1991;324:595-600.
-
(1991)
N Engl J Med
, vol.324
, pp. 595-600
-
-
Kemper, P.1
Murtaugh, C.M.2
-
2
-
-
0028921708
-
Prevalence, age distribution, and gender of patients with atrial fibrillation: Analysis and implications
-
Feinberg WM, Blackshear JL, Laupacis A et al. Prevalence, age distribution, and gender of patients with atrial fibrillation: Analysis and implications. Arch Intern Med 1995;155:469-473.
-
(1995)
Arch Intern Med
, vol.155
, pp. 469-473
-
-
Feinberg, W.M.1
Blackshear, J.L.2
Laupacis, A.3
-
3
-
-
85047690005
-
Use of warfarin for nonvalvular atrial fibrillation in nursing home patients
-
Lackner TE, Battis GN. Use of warfarin for nonvalvular atrial fibrillation in nursing home patients. Arch Fam Med 1995;4:1017-1026.
-
(1995)
Arch Fam Med
, vol.4
, pp. 1017-1026
-
-
Lackner, T.E.1
Battis, G.N.2
-
4
-
-
0023625745
-
Atrial fibrillation: A major contributor to stroke in the elderly: The Framingham Study
-
Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation: A major contributor to stroke in the elderly: The Framingham Study. Arch Intern Med 1987;147:1561-1564.
-
(1987)
Arch Intern Med
, vol.147
, pp. 1561-1564
-
-
Wolf, P.A.1
Abbott, R.D.2
Kannel, W.B.3
-
5
-
-
0025779484
-
Atrial fibrillation as an independent risk factor for stroke: The Framingham Study
-
Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke 1991;22:983-988.
-
(1991)
Stroke
, vol.22
, pp. 983-988
-
-
Wolf, P.A.1
Abbott, R.D.2
Kannel, W.B.3
-
6
-
-
0028244264
-
Risk factors for stroke and efficacy of anti-thrombotic therapy in atrial fibrillation: Analysis of pooled data from five randomized controlled trials
-
Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of anti-thrombotic therapy in atrial fibrillation: Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994;154:1449-1457.
-
(1994)
Arch Intern Med
, vol.154
, pp. 1449-1457
-
-
-
7
-
-
0025241137
-
The effect of low-dose warfarin on risk of stroke in patients with nonrheumatic atrial fibrillation
-
The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med 1990;323:1505-1511.
-
(1990)
N Engl J Med
, vol.323
, pp. 1505-1511
-
-
-
8
-
-
0030964477
-
Atrial fibrillation and stroke prevention in the long-term care setting
-
7a. Gurwitz JH, Monette J, Rochon PA et al. Atrial fibrillation and stroke prevention in the long-term care setting. Arch Intern Med 1997;157:978-984.
-
(1997)
Arch Intern Med
, vol.157
, pp. 978-984
-
-
Gurwitz, J.H.1
Monette, J.2
Rochon, P.A.3
-
9
-
-
0025233476
-
Physician variation in anticoagulating patients with atrial fibrillation
-
Chang HJ, Bell JR, Deroo DB et al. Physician variation in anticoagulating patients with atrial fibrillation. Arch Intern Med 1990;150:81-84.
-
(1990)
Arch Intern Med
, vol.150
, pp. 81-84
-
-
Chang, H.J.1
Bell, J.R.2
Deroo, D.B.3
-
10
-
-
0023053778
-
Physicians' attitudes to four common problems: Hypertension, atrial fibrillation, transjent ischaemic attacks, and angina pectoris
-
Bucknall CA, Morris GK, Mitchell JRA. Physicians' attitudes to four common problems: Hypertension, atrial fibrillation, transjent ischaemic attacks, and angina pectoris. Br Med J 1986;293:739-742.
-
(1986)
Br Med J
, vol.293
, pp. 739-742
-
-
Bucknall, C.A.1
Morris, G.K.2
Mitchell, J.R.A.3
-
11
-
-
0025954635
-
Physicians' attitudes toward oral anticoagulants and antiplatelet agents for stroke prevention in elderly patients with atrial fibrillation
-
Kutner M, Nixon G, Silverstone F. Physicians' attitudes toward oral anticoagulants and antiplatelet agents for stroke prevention in elderly patients with atrial fibrillation. Arch Intern Med 1991;151:1950-1953.
-
(1991)
Arch Intern Med
, vol.151
, pp. 1950-1953
-
-
Kutner, M.1
Nixon, G.2
Silverstone, F.3
-
12
-
-
0027329935
-
Underuse of warfarin is multifactorial
-
Dow L, Bertagne B. Underuse of warfarin is multifactorial. Br Med J 1993;307:1492-1493.
-
(1993)
Br Med J
, vol.307
, pp. 1492-1493
-
-
Dow, L.1
Bertagne, B.2
-
13
-
-
0027908776
-
Doctors reluctant despite evidence
-
King D, Davies KN. Doctors reluctant despite evidence. Br Med J 1993;307:1494.
-
(1993)
Br Med J
, vol.307
, pp. 1494
-
-
King, D.1
Davies, K.N.2
-
14
-
-
0024316072
-
Major bleeding in outpatients treated with warfarin: Incidence and prediction by factors known at the start of outpatient therapy
-
Landefeld CS, Goldman L. Major bleeding in outpatients treated with warfarin: Incidence and prediction by factors known at the start of outpatient therapy. Am J Med 1989;87:144-152.
-
(1989)
Am J Med
, vol.87
, pp. 144-152
-
-
Landefeld, C.S.1
Goldman, L.2
-
15
-
-
0024315189
-
Prothrombin time ration and other factors associated with bleeding in patients treated with warfarin
-
Petitti DB, Strom BL, Melmon KL. Prothrombin time ration and other factors associated with bleeding in patients treated with warfarin. J Clin Epidemiol 1989;42:759-764.
-
(1989)
J Clin Epidemiol
, vol.42
, pp. 759-764
-
-
Petitti, D.B.1
Strom, B.L.2
Melmon, K.L.3
-
16
-
-
0025896681
-
Bleeding complications to anticoagulant therapy: Multivariate analysis of 1010 treatment years in 551 outpatients
-
Launbjerg J, Egeblad H, Heaf J et al. Bleeding complications to anticoagulant therapy: Multivariate analysis of 1010 treatment years in 551 outpatients. J Intern Med 1991;229:351-355.
-
(1991)
J Intern Med
, vol.229
, pp. 351-355
-
-
Launbjerg, J.1
Egeblad, H.2
Heaf, J.3
-
17
-
-
0023819925
-
Age-related risks of long-term anticoagulant therapy
-
Gurwitz JH, Goldberg RJ, Holden A et al. Age-related risks of long-term anticoagulant therapy. Arch Intern Med 1988;148:1733-1736.
-
(1988)
Arch Intern Med
, vol.148
, pp. 1733-1736
-
-
Gurwitz, J.H.1
Goldberg, R.J.2
Holden, A.3
-
18
-
-
0027457034
-
Risk factors for complications of chronic anticoagulation. A multicenter study
-
Warfarin-Optimized Outpatient Follow-up Study Group.
-
Fihn SD, McDonell M, Martin D et al. Risk factors for complications of chronic anticoagulation. A multicenter study. Warfarin-Optimized Outpatient Follow-up Study Group. Ann Intern Med 1993;118:511-520.
-
(1993)
Ann Intern Med
, vol.118
, pp. 511-520
-
-
Fihn, S.D.1
McDonell, M.2
Martin, D.3
-
19
-
-
0029938169
-
Management and prognosis of life-threatening bleeding during warfarin therapy
-
White RH, McKittrick T, Takakuwa J et al. Management and prognosis of life-threatening bleeding during warfarin therapy. Arch Intern Med 1996;156:1197-1201.
-
(1996)
Arch Intern Med
, vol.156
, pp. 1197-1201
-
-
White, R.H.1
McKittrick, T.2
Takakuwa, J.3
-
20
-
-
0030317303
-
The risk for and severity of bleeding complications in elderly patients treated with warfarin
-
Fihn SD, Callahan CM, Martin DC et al. The risk for and severity of bleeding complications in elderly patients treated with warfarin. Ann Intern Med 1996;124:970-979.
-
(1996)
Ann Intern Med
, vol.124
, pp. 970-979
-
-
Fihn, S.D.1
Callahan, C.M.2
Martin, D.C.3
-
21
-
-
0028343127
-
Risk factors for intracranial hemorrhage in outpatients taking warfarin
-
Hylek EM, Singer DE. Risk factors for intracranial hemorrhage in outpatients taking warfarin. Ann Intern Med 1994;120:897-902.
-
(1994)
Ann Intern Med
, vol.120
, pp. 897-902
-
-
Hylek, E.M.1
Singer, D.E.2
-
22
-
-
0028785453
-
Antithrombotic therapy in atrial fibrillation
-
Laupacis A, Albers G, Dalen J et al. Antithrombotic therapy in atrial fibrillation. Chest 1995;108(suppl 4):352-359S.
-
(1995)
Chest
, vol.108
, Issue.4 SUPPL.
-
-
Laupacis, A.1
Albers, G.2
Dalen, J.3
-
23
-
-
0028840258
-
Hemorrhagic complications of anticoagulant treatment
-
Levine MN, Raskob G, Landefeld S, Hirsh J. Hemorrhagic complications of anticoagulant treatment. Chest 1995;108(suppl 4):276-290S.
-
(1995)
Chest
, vol.108
, Issue.4 SUPPL.
-
-
Levine, M.N.1
Raskob, G.2
Landefeld, S.3
Hirsh, J.4
-
24
-
-
0029070127
-
Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia
-
The European Atrial Fibrillation Trial Study Group. Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia. N Engl J Med 1995;333:5-10.
-
(1995)
N Engl J Med
, vol.333
, pp. 5-10
-
-
-
25
-
-
0029741822
-
An analysis of the lowest effective intensity of prophylactic anticoagulation of patients with nonrheumatic atrial fibrillation
-
Hylek EM, Skates SJ, Sheehan MA, Singer DE. An analysis of the lowest effective intensity of prophylactic anticoagulation of patients with nonrheumatic atrial fibrillation. N Engl J Med 1996;335:540-546.
-
(1996)
N Engl J Med
, vol.335
, pp. 540-546
-
-
Hylek, E.M.1
Skates, S.J.2
Sheehan, M.A.3
Singer, D.E.4
-
26
-
-
0029741823
-
The Scylla and Charybdis of oral anticoagulant treatment
-
Rosendall FR. The Scylla and Charybdis of oral anticoagulant treatment. N Engl J Med 1996;335:587-589.
-
(1996)
N Engl J Med
, vol.335
, pp. 587-589
-
-
Rosendall, F.R.1
-
27
-
-
0028833019
-
Physician attitudes about anticoagulation for nonvalvular atrial fibrillation in the elderly
-
McCrory DC, Matchar DB, Samsa G et al. Physician attitudes about anticoagulation for nonvalvular atrial fibrillation in the elderly. Arch Intern Med 1995;155:277-281.
-
(1995)
Arch Intern Med
, vol.155
, pp. 277-281
-
-
McCrory, D.C.1
Matchar, D.B.2
Samsa, G.3
-
29
-
-
1842400637
-
Anticoagulation to prevent stroke in atrial fibrillation
-
Di-Marco JP, Prystowsky EN, eds. Armonk, NY: Futura Publishing Company, app
-
Singer DE. Anticoagulation to prevent stroke in atrial fibrillation. In: Di-Marco JP, Prystowsky EN, eds. Atrial Arrhythmias: State of the Art. Armonk, NY: Futura Publishing Company, 1995, pp 313-326. [app]
-
(1995)
Atrial Arrhythmias: State of the Art
, pp. 313-326
-
-
Singer, D.E.1
|